Eltoprazine HCl ( DrugBank: Eltoprazine )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	2

6. Parkinson disease

---

Clinical trials : 2,307 /  Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02439125 (ClinicalTrials.gov)	May 2015	13/4/2015	A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients	Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, 4-way Crossover, Dose-finding Study, of Eltoprazine Safety, Tolerability and Efficacy in the Treatment of Levodopa-induced Dyskinesia in Patients With Parkinson's Disease	Parkinson's Disease;Dyskinesia	Drug: Eltoprazine HCl;Drug: Placebo	Amarantus BioScience Holdings, Inc.	NULL	Active, not recruiting	30 Years	85 Years	Both	60	Phase 2	United States
2	EUCTR2009-015928-28-SE (EUCTR)	07/10/2010	13/08/2010	A double-blind, randomized, placebo controlled, dose finding study of oral eltoprazine for treatment of levodopa-induced dyskinesias (LID) in a levodopa challenge-dose setting in Parkinsons Disease. - ELTODYS09	A double-blind, randomized, placebo controlled, dose finding study of oral eltoprazine for treatment of levodopa-induced dyskinesias (LID) in a levodopa challenge-dose setting in Parkinsons Disease. - ELTODYS09	Dyskinesias related to levodopa treatment in Parkinson´s disease	Product Name: Eltoprazine HCl Product Code: Eltoprazine HCl	PsychoGenics Inc	NULL	Not Recruiting			Female: yes Male: yes	24		Sweden